News

Latest

Sep 18, 2019
For the fourth consecutive year, AHA sponsored the Annual Congressional Black Caucus Spouses’ Community Breakfast and Health Fair for disadvantaged men and women.
Sep 17, 2019
The AHA today commented on provisions related to surprise medical billing legislation that the House Education and Labor Committee could consider soon.
Sep 17, 2019
A bipartisan group of 92 members of Congress yesterday urged the Food and Drug Administration to prioritize the release of an interagency task force report on the root causes of drug shortages and recommendations to address them.
Sep 17, 2019
The Alliance for Addiction Payment Reform, of which the AHA is a member, is partnering with health care providers and payers to test an alternative payment model for addiction treatment and recovery in Connecticut, Kentucky, North Carolina, Tennessee, Texas and Washington, D.C.
Sep 17, 2019
Sens. Mazie Hirono, D-Hawaii, and Richard Blumenthal, D-Conn., today introduced legislation that would prohibit using federal funds to implement, administer or enforce the Department of Homeland Security’s public charge rule.
Sep 17, 2019
Based on guidelines used by the Department of Justice and Federal Trade Commission to assess market competition, 75% of U.S. commercial health insurance markets were highly concentrated in 2018, up from 71% in 2014.
Sep 16, 2019
The Centers for Disease Control and Prevention today activated its Emergency Operations Center to enhance the inter-agency response to the outbreak of lung injuries associated with e-cigarette use.
Sep 16, 2019
The Centers for Medicare & Medicaid Services should make its proposed Medicare bundled payment model for radiation oncology voluntary, delay the start date and “balance the risk versus reward equation much more appropriately,” AHA told the agency.
Sep 16, 2019
Transportation Secretary Elaine Chao last week named a committee to advise Congress and the departments of Health and Human Services and Transportation on issues relating to air ambulance services and patient billing.
Sep 16, 2019
Rebates reduced the growth in Medicare Part D spending for brand-name drugs between 2011 and 2015, but spending for brand-name drugs with rebates still grew by $2 billion or over the five-year period